Vivani Medical
Закрыт
1.08 -3.57
Обзор
Изменение цены акций
24 ч
Мин.
1.08
Макс.
1.11
Доход | -147K -6.8M |
|---|---|
Сотрудники | 42 |
Рекомендации | Покупка |
|---|---|
Прогноз на 12 месяцев | +240.91% upside |
Следующий отчет о доходах | 11 авг. 2026 г. |
|---|
Рыночная капитализация | 3.4M 80M |
|---|---|
Предыдущая цена открытия | 4.65 |
Предыдущая цена закрытия | 1.08 |
Vivani Medical График
Прошлые результаты не являются надежным индикатором будущих результатов.
О компании Vivani Medical
Vivani Medical, Inc., a preclinical stage biopharmaceutical company, engages in the development of miniaturized and subdermal implants that treat chronic diseases. The company uses its NanoPortal implant technology to develop and potentially commercialize drug implant candidates in the treatment of chronic disease, medication non-adherence. Its pipeline includes NPM-115, a high-dose exenatide implant candidate is in preclinical stage development for the treatment of chronic weight management in patients with obesity or overweight; NPM-119, an exenatide implant candidate is in preclinical stage development for the treatment of patients with type 2 diabetes; NPM-139, a miniature, subdermal GLP-1 implant in development for chronic weight management; and OKV-119, an exenatide implant is under development for metabolic diseases in cats including for the treatment of obesity and diabetes. The company is headquartered in Alameda, California.
